MRS2 (Magnesium Homeostasis Factor Homolog) is a mitochondrial inner membrane protein critical for Mg²⁺ transport and mitochondrial function. Antibodies targeting MRS2 are used in research to study its role in energy metabolism, mitochondrial diseases, and Mg²⁺ regulation.
N-Glycosylated MRS2 Isoforms: Antibodies (e.g., ABIN7043335) have identified two MRS2 isoforms: glycosylated (higher molecular weight) and unglycosylated (lower molecular weight). Glycosylation reduces Mg²⁺ influx capacity, linking it to cellular energy demand (glycolysis vs. oxidative phosphorylation) .
Disease Relevance: Increased glycosylated MRS2 is observed in mitochondrial disease patient fibroblasts, suggesting a potential diagnostic biomarker .
Detection: Antibodies like ABIN7043335 and ABIN6743527 are used to assess MRS2 expression levels in mitochondrial isolates or cell lysates .
Glycosylation Analysis: PNGase F treatment shifts MRS2 bands, confirming post-translational modifications .
Tissue Localization: NBP2-34200 stains MRS2 in human skeletal muscle (myocytes) and placental trophoblasts, highlighting its role in energy-intensive tissues .
Mitochondrial Mg²⁺ Uptake: Overexpression of hMrs2 in HEK-293F cells increases Mg²⁺ influx, validated via mitochondrial assays and antibody-based detection .